Zymeworks Inc logo

Zymeworks Inc - Registered Shs

1
4
NAS:ZYME (USA)   Registered Shs
$ 8.52 -0.02 (-0.23%) 07:08 PM EST
At Loss
P/B:
1.37
Market Cap:
$ 602.41M
Enterprise V:
$ 284.00M
Volume:
413.27K
Avg Vol (2M):
690.43K
Trade In:
Volume:
413.27K
At Loss
Avg Vol (2M):
690.43K

Business Description

Zymeworks Inc logo
Zymeworks Inc
NAICS : 325412 SIC : 2836
ISIN : CA98985W1023

Share Class Description:

ZYME: Registered Shs
Description
Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated product candidates. Its clinical candidate, zanidatamab, is a novel Azymetric HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. The company is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.
Name Current Vs Industry Vs History
Cash-To-Debt 13.68
Equity-to-Asset 0.79
Debt-to-Equity 0.06
Debt-to-EBITDA -0.19
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 1.4
Distress
Grey
Safe
Beneish M-Score -2.06
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 29.51
9-Day RSI 38.64
14-Day RSI 42.08
6-1 Month Momentum % 0.66
12-1 Month Momentum % 12.32

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 6.92
Quick Ratio 6.92
Cash Ratio 6.07
Days Sales Outstanding 337.68

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -15.1
Shareholder Yield % -3.84

Financials (Next Earnings Date:2024-08-09 Est.)

ZYME's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:ZYME

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Zymeworks Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 50.464
EPS (TTM) ($) -1.78
Beta 1.41
Volatility % 47.79
14-Day RSI 42.08
14-Day ATR ($) 0.434259
20-Day SMA ($) 8.82725
12-1 Month Momentum % 12.32
52-Week Range ($) 6.015 - 13.14
Shares Outstanding (Mil) 70.7

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Zymeworks Inc Filings

Filing Date Document Date Form
No Filing Data

Zymeworks Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Zymeworks Inc Frequently Asked Questions

What is Zymeworks Inc(ZYME)'s stock price today?
The current price of ZYME is $8.52. The 52 week high of ZYME is $13.14 and 52 week low is $6.02.
When is next earnings date of Zymeworks Inc(ZYME)?
The next earnings date of Zymeworks Inc(ZYME) is 2024-08-09 Est..
Does Zymeworks Inc(ZYME) pay dividends? If so, how much?
Zymeworks Inc(ZYME) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1